Wockhardt Puts Up Superbug Fight With Punchy Broad Spectrum Antibiotic
Wockhardt has received approvals in India for two novel broad spectrum antibiotics with "advantageous" safety features over older MRSA drugs and the firm hopes to take them to other emerging markets as well, with China on the radar.